...
首页> 外文期刊>Infection and Drug Resistance >AmpR Increases the Virulence of Carbapenem-Resistant Klebsiella pneumoniae by Regulating the Initial Step of Capsule Synthesis
【24h】

AmpR Increases the Virulence of Carbapenem-Resistant Klebsiella pneumoniae by Regulating the Initial Step of Capsule Synthesis

机译:通过调节胶囊合成的初始步骤,AMPR增加了抗抵抗性抗肺炎氏菌氏肺炎的毒力

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background: Non-hypermucoviscous carbapenem-resistant Klebsiella pneumoniae with enhanced virulence lacking hvKP-specific virulence factors is uncommon, and the virulence mechanisms of this organism are not understood. Methods: Following a retrospective study of carbapenem-resistant K. pneumoniae based on core genome multilocus sequence typing (cgMLST), isolates that caused high mortality were investigated with a genome-wide association study (GWAS), proteome analysis and an animal model. Results: The subclone of sequence type 11 (ST11) K. pneumoniae , which belongs to complex type 3176 (CT3176) and K-locus 47 (KL47), was highlighted due to the high mortality of infected patients. GWAS analysis showed that transcriptional regulatory gene ampR was associated with the CT3176 isolates. In a mouse model, the mortality, bacterial load and pathological changes of mice infected with ampR -carrying isolates were distinct from those infected with ampR -null isolates. The ampR gene that enhances the virulence of the non-hypermucoviscous KL47 strain was unable to enhance the virulence of hypermucoviscous KL1 strain. Proteome analysis showed that the expression of WcaJ in the ampR isolates was significantly higher than that in the ampR ? isolates. Quantification of capsular polysaccharide confirmed that more capsule polysaccharide was produced by ampR and ampR -complementary strains compared to ampR ? strains. It is suggested that the enhancement of the initial stage of capsule synthesis may be the cause of the enhanced virulence of these non-hypermucoviscous ST11 carbapenem-resistant K. pneumoniae isolates. Conclusion: Non-hypermucoviscous ST11 carbapenem-resistant K. pneumoniae with enhanced virulence warrants continued surveillance and investigation.
机译:背景:抗缺乏HVKP特异性毒力因子的增强毒力的非高水性碳抗性肺炎肺炎是罕见的,并且不明白这种生物体的毒力机制。方法:通过基于核心基因组多点序列(CGMLST)的肺癌抗性K.肺炎肺炎,研究了引起高死亡率的分离物与基因组 - 宽的关联研究(GWAS),蛋白质组分析和动物模型研究。结果:由于感染患者的高死亡率,突出了序列类型11(ST11)K.肺炎的序列型11(ST11)K.Pneumoniae,其属于复杂的3176(CT3176)和K-Locus 47(KL47)。 GWAS分析表明,转录调节基因AMPR与CT3176分离物相关。在小鼠模型中,用AMPR-Carrying分离物感染的小鼠的死亡率,细菌载荷和病理变化与感染的AMPR -NULL分离株的小鼠不同。增强非高制量的KL47菌株的毒力的AMPR基因不能增强高制量的KL1菌株的毒力。蛋白质组分析表明,AMPR分离株WCAJ的表达明显高于AMPR中的?隔离。囊状多糖的定量证实,与AMPR相比,通过AMPR和AMPR型菌株生产更多胶囊多糖?菌株。建议提高胶囊合成的初始阶段可能是这些非高水性ST11 CarbapeNem抗性K.肺炎群分离物的增强毒力的原因。结论:非高水性ST11 CarbapeNem抗性K.肺炎肺炎,具有增强的毒力量认股权证继续监测和调查。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号